Strategic Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.37M | Sell |
2,795
-2
| -0.1% | -$1.08K | 0.23% | 89 |
|
|
2025
Q4 | $1.62M | Sell |
2,797
-96
| -3% | -$54.3K | 0.25% | 87 |
|
|
2025
Q3 | $1.4M | Sell |
2,893
-256
| -8% | -$119K | 0.23% | 85 |
|
|
2025
Q2 | $1.28M | Sell |
3,149
-336
| -10% | -$140K | 0.25% | 78 |
|
|
2025
Q1 | $1.73M | Sell |
3,485
-176
| -5% | -$95.3K | 0.33% | 66 |
|
|
2024
Q4 | $1.9M | Sell |
3,661
-2,453
| -40% | -$1.35M | 0.34% | 59 |
|
|
2024
Q3 | $3.78M | Sell |
6,114
-1,118
| -15% | -$662K | 0.71% | 34 |
|
|
2024
Q2 | $4M | Sell |
7,232
-50
| -0.7% | -$28.6K | 0.78% | 26 |
|
|
2024
Q1 | $4.23M | Sell |
7,282
-175
| -2% | -$98.2K | 0.83% | 26 |
|
|
2023
Q4 | $3.96M | Sell |
7,457
-254
| -3% | -$123K | 0.75% | 26 |
|
|
2023
Q3 | $3.9M | Buy |
7,711
+96
| +1% | +$51.2K | 0.77% | 32 |
|
|
2023
Q2 | $3.97M | Buy |
7,615
+35
| +0.5% | +$18.9K | 0.76% | 34 |
|
|
2023
Q1 | $4.37M | Sell |
7,580
-286
| -4% | -$161K | 0.88% | 32 |
|
|
2022
Q4 | $4.33M | Buy |
7,866
+8
| +0.1% | +$4.24K | 0.96% | 29 |
|
|
2022
Q3 | $3.98M | Sell |
7,858
-85
| -1% | -$47.6K | 0.88% | 32 |
|
|
2022
Q2 | $4.32M | Sell |
7,943
-132
| -2% | -$72.7K | 0.9% | 30 |
|
|
2022
Q1 | $4.77M | Sell |
8,075
-244
| -3% | -$140K | 0.83% | 35 |
|
|
2021
Q4 | $5.55M | Buy |
8,319
+1,057
| +15% | +$660K | 0.79% | 37 |
|
|
2021
Q3 | $4.15M | Buy |
7,262
+68
| +0.9% | +$37.3K | 0.89% | 22 |
|
|
2021
Q2 | $3.63M | Buy |
7,194
+133
| +2% | +$62.8K | 0.94% | 21 |
|
|
2021
Q1 | $3.22M | Buy |
7,061
+33
| +0.5% | +$15.8K | 0.93% | 21 |
|
|
2020
Q4 | $3.52M | Buy |
7,028
+184
| +3% | +$86.3K | 1.02% | 22 |
|
|
2020
Q3 | $3.08M | Sell |
6,844
-324
| -5% | -$134K | 1.03% | 22 |
|
|
2020
Q2 | $2.94M | Buy |
7,168
+551
| +8% | +$185K | 1.1% | 20 |
|
|
2020
Q1 | $2.03M | Sell |
6,617
-512
| -7% | -$161K | 0.89% | 27 |
|
|
2019
Q4 | $2.32M | Sell |
7,129
-493
| -6% | -$149K | 0.81% | 31 |
|
|
2019
Q3 | $2.22M | Buy |
7,622
+519
| +7% | +$149K | 0.83% | 31 |
|
|
2019
Q2 | $2.08M | Sell |
7,103
-50
| -0.7% | -$13.8K | 0.79% | 35 |
|
|
2019
Q1 | $1.96M | Sell |
7,153
-13
| -0.2% | -$3.23K | 0.76% | 33 |
|
|
2018
Q4 | $1.6M | Sell |
7,166
-989
| -12% | -$232K | 0.7% | 38 |
|
|
2018
Q3 | $1.99M | Buy |
8,155
+31
| +0.4% | +$7.13K | 0.73% | 36 |
|
|
2018
Q2 | $1.68M | Buy |
8,124
+149
| +2% | +$31.6K | 0.68% | 41 |
|
|
2018
Q1 | $1.65M | Buy |
7,975
+227
| +3% | +$47.6K | 0.68% | 41 |
|
|
2017
Q4 | $1.47M | Buy |
7,748
+721
| +10% | +$138K | 0.6% | 49 |
|
|
2017
Q3 | $1.33M | Buy |
7,027
+310
| +5% | +$56.1K | 0.58% | 53 |
|
|
2017
Q2 | $1.17M | Sell |
6,717
-463
| -6% | -$77.8K | 0.54% | 59 |
|
|
2017
Q1 | $1.1M | Buy |
7,180
+694
| +11% | +$106K | 0.52% | 58 |
|
|
2016
Q4 | $915K | Buy |
6,486
+86
| +1% | +$12.7K | 0.48% | 67 |
|
|
2016
Q3 | $1.02M | Buy |
6,400
+533
| +9% | +$82.1K | 0.57% | 59 |
|
|
2016
Q2 | $867K | Sell |
5,867
-315
| -5% | -$46.5K | 0.5% | 68 |
|
|
2016
Q1 | $875K | Buy |
6,182
+551
| +10% | +$73.8K | 0.5% | 66 |
|
|
2015
Q4 | $799K | Sell |
5,631
-500
| -8% | -$66.7K | 0.52% | 64 |
|
|
2015
Q3 | $750K | Hold |
6,131
| – | – | 0.52% | 66 |
|
|
2015
Q2 | $796K | Sell |
6,131
-344
| -5% | -$44.8K | 0.51% | 67 |
|
|
2015
Q1 | $764K | Buy |
6,475
+344
| +6% | +$44.3K | 0.49% | 69 |
|
|
2014
Q4 | $768K | Sell |
6,131
-103
| -2% | -$12.5K | 0.5% | 70 |
|
|
2014
Q3 | $759K | Sell |
6,234
-241
| -4% | -$29.3K | 0.5% | 69 |
|
|
2014
Q2 | $764K | Hold |
6,475
| – | – | 0.49% | 69 |
|
|
2014
Q1 | $779K | Buy |
6,475
+183
| +3% | +$21.8K | 0.52% | 63 |
|
|
2013
Q4 | $701K | Hold |
6,292
| – | – | 0.48% | 73 |
|
|
2013
Q3 | $580K | Sell |
6,292
-300
| -5% | -$27.1K | 0.48% | 70 |
|
|
2013
Q2 | $569K | Buy |
+6,592
| New | +$549K | 0.51% | 63 |
|
Other funds holding TMO
VCM
Strategic Advisors's TMO Position: Q1 2026 in Review
Strategic Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.07% in Q1 2026, selling an estimated $1.08K and leaving 2,795 shares worth $1.37M. The position accounts for 0.23% of the portfolio, ranked #89.
Strategic Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.55M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Strategic Advisors held 2,795 shares of Thermo Fisher Scientific worth $1.37M as of Q1 2026.
- Strategic Advisors sold 2 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.08K.
- Thermo Fisher Scientific made up 0.23% of Strategic Advisors's portfolio in Q1 2026, its #89 holding.
- Strategic Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Strategic Advisors's Thermo Fisher Scientific position peaked at $5.55M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Strategic Advisors's 13F filing for Q1 2026, filed 14 May 2026.